IBOV 172,060.43 ▲ 0.42% IPC MEX 72,006.05 ▲ 0.16% MERVAL 2,848,945 — — USD/BRL5.58▼ 0.04% USD/MXN18.58▼ 0.09% USD/CLP982.08▼ 0.22% USD/COP3,279▼ 0.85% USD/PEN3.41▼ 0.02% USD/ARS1,544▼ 0.03% USD/UYU40.52▲ 3.70% USD/PYG6,174▲ 3.14% USD/BOB11.63▲ 0.92% USD/DOP60.48▲ 0.05% USD/CRC446.01▲ 1.79% USD/GTQ7.64▲ 3.16% USD/HNL26.90▲ 3.29% USD/NIO36.62▲ 2.73% USD/VES902.19▲ 0.19% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.49▲ 2.41% USD/TTD6.72▲ 2.22% EUR/BRL6.19▼ 0.68% BRENT 93.22 ▲ 0.50% WTI 86.94 ▲ 0.47% IRON ORE 161.91 — — COPPER 6.23 ▼ 0.73% GOLD 3,969 ▼ 0.78% SILVER 51.42 ▼ 0.90% SOY 1,226 ▼ 0.24% CORN 447.75 ▼ 0.06% WHEAT 599.50 — 0.00% COFFEE 265.45 ▼ 2.19% SUGAR 18.47 ▲ 2.10% ORANGE JUICE 146.60 ▼ 0.10% COTTON 82.35 ▲ 4.65% COCOA 5,061 ▲ 6.73% BEEF 218.98 ▼ 0.10% CATTLE 327.80 ▼ 0.77% LITHIUM 61.07 ▲ 1.82% PETR4 43.55 ▼ 3.11% VALE3 64.43 ▼ 0.57% ITUB4 41.72 ▲ 1.26% BBDC4 14.33 ▼ 1.44% ABEV3 15.85 ▲ 0.38% BBAS3 16.89 ▼ 1.23% B3SA3 14.80 ▲ 2.21% WEGE3 51.61 ▲ 1.30% PRIO3 61.47 ▲ 2.42% SUZB3 53.80 ▼ 1.21% RENT3 30.24 ▲ 1.51% AZZA3 15.37 ▲ 4.34% CSAN3 3.03 ▲ 13.06% RAIZ4 0.30 ▼ 98.60% PCAR3 2.54 ▼ 0.78% GMAT3 4.08 ▲ 7.09% PSSA3 45.98 ▼ 1.48% CVCB3 0.86 — 0.00% POSI3 3.32 ▲ 5.40% SLCE3 17.05 ▼ 0.23% NATU3 5.62 ▲ 1.26% BRKM5 2.92 — 0.00% RANI3 8.39 ▼ 0.71% CSNA3 4.52 ▲ 3.20% IBOV 172,060.43 ▲ 0.42% IPC MEX 72,006.05 ▲ 0.16% MERVAL 2,848,945 — — USD/BRL 5.58 ▲ 0.03% USD/MXN 18.61 ▲ 0.03% USD/CLP 982.08 ▼ 0.22% USD/COP 3,279 ▼ 0.85% USD/PEN 3.41 ▼ 0.02% USD/ARS 1,544 ▼ 0.11% USD/UYU 40.52 ▲ 3.70% USD/PYG 6,174 ▲ 3.14% USD/BOB 11.63 ▲ 1.12% USD/DOP 60.48 ▲ 0.05% USD/CRC 446.01 ▲ 1.79% USD/GTQ 7.64 ▲ 3.16% USD/HNL 26.90 ▲ 3.29% USD/NIO 36.62 ▲ 2.73% USD/VES 902.19 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.49 ▲ 2.41% USD/TTD 6.72 ▲ 2.22% EUR/BRL 6.19 ▼ 0.62% BRENT 93.22 ▲ 0.50% WTI 86.94 ▲ 0.47% IRON ORE 161.91 — — COPPER 6.23 ▼ 0.73% GOLD 3,969 ▼ 0.78% SILVER 51.42 ▼ 0.90% SOY 1,226 ▼ 0.24% CORN 447.75 ▼ 0.06% WHEAT 599.50 — 0.00% COFFEE 265.45 ▼ 2.19% SUGAR 18.47 ▲ 2.10% ORANGE JUICE 146.60 ▼ 0.10% COTTON 82.35 ▲ 4.65% COCOA 5,061 ▲ 6.73% BEEF 218.98 ▼ 0.10% CATTLE 327.80 ▼ 0.77% LITHIUM 61.07 ▲ 1.82% PETR4 43.55 ▼ 3.11% VALE3 64.43 ▼ 0.57% ITUB4 41.72 ▲ 1.26% BBDC4 14.33 ▼ 1.44% ABEV3 15.85 ▲ 0.38% BBAS3 16.89 ▼ 1.23% B3SA3 14.80 ▲ 2.21% WEGE3 51.61 ▲ 1.30% PRIO3 61.47 ▲ 2.42% SUZB3 53.80 ▼ 1.21% RENT3 30.24 ▲ 1.51% AZZA3 15.37 ▲ 4.34% CSAN3 3.03 ▲ 13.06% RAIZ4 0.30 ▼ 98.60% PCAR3 2.54 ▼ 0.78% GMAT3 4.08 ▲ 7.09% PSSA3 45.98 ▼ 1.48% CVCB3 0.86 — 0.00% POSI3 3.32 ▲ 5.40% SLCE3 17.05 ▼ 0.23% NATU3 5.62 ▲ 1.26% BRKM5 2.92 — 0.00% RANI3 8.39 ▼ 0.71% CSNA3 4.52 ▲ 3.20%
since 2009
Thursday, November 12, 2026

Life & Society Local Politics

Judge in Rio Allows Parkinson’s Patient to Plant Marijuana for Treatment

By · · 4 min read

RIO DE JANEIRO, BRAZIL – Judge Rosana Navega, of the 1st Criminal Court of Niterói in the State of Rio de Janeiro, granted an injunction for a woman to plant and transport Cannabis sativa, the marijuana plant, for medicinal purposes. She cultivates the plant to extract the oil used as medicine to treat Parkinson’s disease.

In the ruling, Judge Rosana Navega points out that should the injunction for the cultivation of cannabis not be granted, the therapeutic treatment that mitigates the woman's pain would be unfeasible due to the import cost of cannabidiol.
In the ruling, Judge Rosana Navega points out that should the injunction for the cultivation of cannabis not be granted, the therapeutic treatment that mitigates the woman’s pain would be unfeasible due to the import cost of cannabidiol.
RT
Ask Rio Times
This story and the bigger picture.
Open the full Ask Rio Times →

According to the medical reports submitted in the case, conventional medication treated the disease palliatively and with side effects. With the fast progression of the disease, manifested in muscle stiffness, memory loss and traces of depression, the lady’s partner began to seek solutions that would provide a better quality of life and dignity to the patient.

They then requested special permission from the National Health Surveillance Agency (ANVISA) to import medicines made from cannabidiol. In the ruling, Judge Rosana Navega points out that should the injunction for the cultivation of cannabis not be granted, the therapeutic treatment that mitigates the woman’s pain would be unfeasible due to high import cost.

“In other words, the extracts of Cannabis Sativa that the patient uses today with good results are equivalent to the extracts imported and allowed by ANVISA, only with more content of other cannabinoids – therapeutic substances – present in Cannabis Sativa, which the patient needs according to medical prescription. In this sense, one of the advantages of handmade oil is the product’s better adequacy to the specific needs of the patients for whom it is intended”.

The magistrate further pointed out an article by physician Dráuzio Varella on the price and red tape required to obtain medicinal cannabis. He recalled that 35 countries, such as Canada, the United Kingdom, and Peru, have adapted their laws so that patients with severe illnesses may use the treatment with medicines derived from the plant.

The LatAm Brief

One email, every weekday morning. What moved in Latin American markets, politics and expat life.

Yesterday’s subject line: “Petrobras to pay shareholders US$2.7 billion”

Free. We send a confirmation link first — nothing arrives until you click it. Unsubscribe with one click in any edition. If you stop opening us for 30 days we stop sending by ourselves, as we assume the interest is no longer there. See our privacy policy. We never share your email.

In Brazil, there are other cases, including Rio de Janeiro, in which patients have been granted legal permission to grow the plant, which is the cheapest and most affordable means of obtaining the medicinal compounds.

“I would also like to point out that the subscribers to the Habeas Corpus initiative have been able to get experts, among them doctors, psychologists, anthropologists, biologists and pharmacists, linked to various social and research institutions, to work with the aforementioned self-cultivation, in particular, the FARMACANABIS project of the Drug Laboratory of the UFRJ Faculty of Pharmacy”.

Brazilian Bar Association of Rio de Janeiro.
Brazilian Bar Association of Rio de Janeiro.

Rio’s Bar Association (OAB-RJ) discusses the medicinal use of cannabidiol

Meanwhile, the Medical Law Commissions (CDMC) and the Special Commission on Sanitary and Health Law (CEDSS) jointly held an event on Wednesday morning, November 13th, to discuss the legalization of cannabidiol. The Secretary of the Medical Law Commission, Elaine Lacerda, opened the event.

Next, the president of the commission on the subject in the Subsection of Barra da Tijuca emphasized that patients who are in treatment for several chronic and neurodegenerative diseases have been bringing the prescription of cannabidiol to the courts.

“These are people who are not being successfully treated with other prescribed drugs, and patients have achieved satisfactory results in treatment with cannabidiol,” she said, noting that in 2015 when ANVISA removed cannabidiol from the list of prohibited substances, many patients managed to begin treatment.

Doctor Janaína Barboza provided some of what is expected from the future of cannabidioid medidicine. She explained that the cannabis plant has entered her therapeutic field as one of the plants she is already prescribing. “But when I studied, I realized that it is not just a plant. It’s ‘the’ plant,” she said.

“We have been deprived of using this molecule therapeutically for about three generations. On the other hand, we accepted as a fact that fluoxetine, for instance, is safe. Since it was developed around forty years ago”, she questioned. She has distinguished the different uses of cannabidiol for medicinal purposes, which include diseases in the nervous system, as well as in the bone system, and also helps to regulate the diet.

This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error

Living in or visiting Rio de Janeiro? See this month's events and our Rio de Janeiro city guide with rents, safety and upcoming concerts.

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →

Brazil runoff date: Sunday, October 25, poll closing times and when results start · Brazil runoff polls: Flávio 51%, Lula 49% · Kalshi and Polymarket odds

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.